https://www.businesstimes.com.sg/companies-markets/consumer-healthcare/valeant-leads-way-steep-price-increase-skin-drugs
Valeant leads the way in steep price increase of skin drugs - The Business Times
TWO drugs sold by Valeant Pharmaceuticals International to treat cancer-related skin conditions increased in price by about 1,700 per cent over the last six...
https://www.foxbusiness.com/markets/canadian-drugmaker-valeant-agrees-to-buy-us-rival-salix-for-about-10-billion-in-cash
Canadian drugmaker Valeant agrees to buy US rival Salix for about $10 billion in cash | Fox Business
Canadian drugmaker Valeant Pharmaceuticals International Inc. has agreed to buy Salix Pharmaceuticals Ltd. for about $10 billion in cash.
https://www.prnewswire.com/news-releases/valeant-announces-pricing-of-private-offering-of-notes-300650702.html
Valeant Announces Pricing Of Private Offering Of Notes
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that Valeant Pharmaceuticals...
valeantannouncespricingprivateoffering
https://www.fool.com/investing/general/2015/10/24/valeant-pharmaceuticals-posts-strong-q3-results.aspx
Valeant Pharmaceuticals Posts Strong Q3 Results | The Motley Fool
Oct 24, 2015 - Solid organic growth helps the drugmaker beat expectations in the third quarter.
valeant pharmaceuticalsthe motleypostsstrongq3
https://www.fool.com/investing/general/2016/05/17/why-pandora-media-southwestern-energy-and-valeant.aspx
Why Pandora Media, Southwestern Energy, and Valeant Pharmaceuticals Jumped Today | The Motley Fool
May 17, 2016 - Even though the market fell sharply today, these stocks rose. Find out why.
https://www.medicaldaily.com/valeant-subpoenaed-us-prosecutors-over-drug-pricing-357350
Valeant Subpoenaed By US Prosecutors Over Drug Pricing
Oct 15, 2015 - Valeant Pharmaceuticals International Inc, under fire for price increases of its two heart drugs, said it was subpoenaed by U.S. prosecutors on its pricing,...
by usvaleantsubpoenaedprosecutorsdrug
https://www.fiercebiotech.com/financials/valeant-ceo-mike-pearson-out-as-embattled-drugmaker-seeks-new-leadership
Valeant CEO Mike Pearson out as embattled drugmaker seeks new leadership | Fierce Biotech
Mar 24, 2016 - In this week's Chutes and Ladders, CEO J. Michael Pearson is leaving Valeant and COO Krish Krishnan is leaving Intrexon. Plus more hirings and retirings...
https://kffhealthnews.org/morning-breakout/on-return-to-work-valeant-ceo-faces-questions-about-business-practices-clinton-ad-attack/
On Return To Work, Valeant CEO Faces Questions About Business Practices - KFF Health News
Mar 2, 2016 - Just back from a two-month medical leave, Valeant Pharmaceutical's Michael Pearson sought to reassure Wall Street analysts over the drugmaker's financial...
https://www.law360.com/articles/889982/ftc-valeant-see-eye-to-eye-on-paragon-divestiture
FTC, Valeant See Eye-To-Eye On Paragon Divestiture - Law360
The U.S. Federal Trade Commission signed off on a settlement with Valeant Pharmaceuticals International Inc. over its 2015 purchase of a contact lens...
to onftcvaleantseeeye
https://www.prnewswire.com/news-releases/valeant-to-participate-at-2018-bank-of-america-merrill-lynch-healthcare-conference-300645622.html
Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") today announced that Joseph C. Papa, chairman and chief executive...
bank of america merrill lynchto participate
https://www.foxbusiness.com/video/3496274427001
Activist Bill Ackman teams up with Valeant to buy Allergan | Fox Business Video
New era for activists?
https://www.fool.com/investing/2018/01/05/3-compelling-reasons-valeant-pharmaceuticals-explo.aspx
3 Compelling Reasons Valeant Pharmaceuticals Exploded Higher by 24% in December | The Motley Fool
Jan 5, 2018 - Valeant took another step forward on its road to redemption, but it still has a long walk ahead.
https://www.fool.com/investing/general/2015/10/30/why-valeant-pharmaceuticals-intl-inc-tumbled-again.aspx
Why Valeant Pharmaceuticals Intl Inc Tumbled Again Today | The Motley Fool
Oct 30, 2015 - More issues with its associated specialty pharmacy, Philidor.
valeant pharmaceuticalsthe motleyintlinc
https://www.newswire.ca/news-releases/valeant-to-sell-dendreon-to-sanpower-group-for-8199-million-in-cash-610186105.html
Valeant To Sell Dendreon To Sanpower Group For $819.9 Million In Cash
/CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that its affiliate has entered into a...
to sell
https://www.prnewswire.com/news-releases/valeant-to-seek-refinancing-of-its-existing-credit-agreement-300646141.html
Valeant To Seek Refinancing of its Existing Credit Agreement
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that it is seeking to amend and...
valeantseekrefinancingexistingcredit
https://www.newswire.ca/news-releases/valeant-pharmaceuticals-to-announce-2012-fourth-quarter-results-on-february-28-2013-511904601.html
Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
/CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast...
valeant pharmaceuticalsto announcefourth quarter
https://investingnews.com/tag/valeant-pharmaceuticals
valeant pharmaceuticals | INN
valeant pharmaceuticalsinn
https://www.insidermonkey.com/blog/why-valeant-tesla-citrix-systems-ruby-tuesday-and-stellar-biotechnologies-are-in-the-spotlight-566105/
Why Valeant, Tesla, Citrix Systems, Ruby Tuesday, and Stellar Biotechnologies Are in the Spotlight...
Although the FOMC meets on Tuesday and Wednesday, the market hasn't been as volatile as it used to be.
https://www.institutionalinvestor.com/article/2bsy81rad9r1kpky6w8ao/portfolio/the-morning-brief-valeant-surges-but-big-problems-remain
The Morning Brief: Valeant Surges, but Big Problems Remain | Institutional Investor
Shares of Valeant Pharmaceuticals International surged 7.4 percent on Monday to close at $28.98 after the drug company made a series of announcements that...
the morningbig problemsbriefvaleantsurges
https://www.cityam.com/valeant-pharmaceuticals-slams-scathing-note-on-drug-sales-in-bid-to-reverse-share-price-spiral/
Valeant Pharmaceuticals slams scathing note on drug sales in bid to reverse share price spiral
Oct 21, 2015 - Under fire drug company Valeant Pharmaceuticals tried to halt its plummeting share price yesterday by hitting back at a damning note that questioned the...
https://www.fool.com/investing/2017/05/04/shocker-valeant-pharmaceuticals-slides-another-16.aspx
Shocker: Valeant Pharmaceuticals Slides Another 16% in April. Here's the Big Reason Why | The...
May 4, 2017 - Despite being valued below its full-year EBITDA forecast, Valeant's debt woes continue to take center stage.
https://www.foxbusiness.com/video/4075892814001
Valeant buys Salix Pharmaceuticals for $10.1B | Fox Business Video
salix pharmaceuticalsfox businessvaleantbuys10
https://www.prnewswire.com/news-releases/valeant-will-release-first-quarter-2018-financial-results-on-may-8-300624661.html
Valeant Will Release First-Quarter 2018 Financial Results On May 8
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") will release its first-quarter 2018 financial results on Tuesday, May...
first quarterfinancial resultsvaleantrelease
https://www.fool.com/investing/2017/05/23/industry-focus-healthcare-05-17-2017.aspx
Valeant and Gilead: Beaten Down Bargains or Truly Terrible? | The Motley Fool
May 23, 2017 - Valeant and Gilead Sciences' are arguably cheap stocks, but big questions remain that still make them risky to buy.
https://www.salon.com/2016/11/18/and-you-thought-all-valeant-did-was-price-gouge-former-executive-at-the-big-pharma-firm-charged-with-fraud/
And you thought all Valeant did was price gouge ... : Former executive at the Big Pharma firm...
Nov 19, 2016 - The pharmaceutical giant vilified for extreme price hikes on medication has been rocked by a $300m fraud scandal
https://www.prnewswire.com/news-releases/valeant-announces-redemption-of-150-million-aggregate-principal-amount-of-its-outstanding-6-375-senior-unsecured-notes-due-2020--300629088.html
Valeant Announces Redemption of $150 Million Aggregate Principal Amount of Its Outstanding 6.375%...
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") today announced that Valeant Pharmaceuticals International, a wholly...
https://www.biospace.com/embattled-valeant-mulls-over-name-change-for-a-fresh-start
Embattled Valeant Mulls Over Name Change For A Fresh Start - BioSpace
a fresh startname changeembattledvaleant
https://www.fool.com/investing/2016/09/09/hillary-clintons-new-prescription-drug-proposal-ta.aspx
Hillary Clinton's New Prescription Drug Proposal Takes Aim at Valeant Pharmaceuticals and Mylan |...
Sep 9, 2016 - Clinton lays out a plan to tackle prescription drug price inflation, but will it work?
https://www.foxbusiness.com/markets/valeant-says-has-received-additional-notices-of-default-due-to-delayed-10-k-filing
Valeant Says Has Received Additional Notices Of Default Due To Delayed 10-K Filing | Fox Business
Valeant Pharmaceuticals International Inc. said Monday it has received additional notices of default on its debt due to the delayed filing of its 10-K.
https://www.buzzsprout.com/2170897/episodes/15435775-the-strategic-negotiations-behind-the-allergan-actavis-merger-amidst-valeant-s-hostile-takeover-bid
The strategic negotiations behind the Allergan-Actavis merger amidst Valeant's hostile takeover bid.
In this episode, we'll explore the 66 billion $ merger negotiations between Allergan and Actavis, and the hostile takeover attempt by Valeant. Joining me again...
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=2&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.biospace.com/b-ackman-b-gobbles-up-almost-five-percent-stake-in-valeant
Ackman Gobbles Up Almost Five Percent Stake in Valeant - BioSpace
five percentackmangobblesalmoststake
https://www.prnewswire.com/news-releases/global-acne-drugs-market-2016-2020---key-vendors-are-allergan-galderma-stiefel--valeant-300187515.html
Global Acne Drugs Market 2016-2020 - Key Vendors are Allergan, Galderma, Stiefel & Valeant
/PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/2hpc7x/global_acne_drugs) has announced the addition of the "Global Acne...
https://kffhealthnews.org/morning-breakout/outgoing-valeant-ceo-to-testify-at-senate-drug-pricing-hearing/
Outgoing Valeant CEO To Testify At Senate Drug Pricing Hearing - KFF Health News
Mar 29, 2016 - In other Valeant news, investors in Sprout -- the female libido pill -- are charging that the company, which bought the product, failed to properly...
https://www.newswire.ca/news-releases/valeant-announces-sale-of-inova-pharmaceuticals-for-930-million-627196361.html
Valeant Announces Sale of iNova Pharmaceuticals for $930 Million
/CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced it has entered into an agreement to sell its iNova...
sale ofinova pharmaceuticalsvaleantannounces930
https://www.newswire.ca/news-releases/valeant-announces-cfo-succession-plan-and-additional-executive-appointment-517498971.html
Valeant Announces CFO Succession Plan And Additional Executive Appointment
/CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that Howard B. Schiller has advised the Company of his decision...
succession planvaleantannouncescfoadditional
https://www.prnewswire.com/news-releases/arbitral-tribunal-decides-in-favor-of-valeant-in-uceris-arbitration-300629202.html
Arbitral Tribunal Decides In Favor Of Valeant In UCERIS Arbitration
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that the Arbitral Tribunal issued a decision (rendered on April...
arbitral tribunaldecidesfavorvaleantuceris
https://www.payscale.com/research/AE/Employer=Valeant_Pharmaceuticals/Hourly_Rate
Valeant Pharmaceuticals Hourly Pay in United Arab Emirates in 2026 | PayScale
Valeant Pharmaceuticals in United Arab Emirates in 2026 - Hourly Rate - Get a free salary comparison based on job title, skills, experience and education....
united arab emiratesvaleant pharmaceuticalspay inhourly2026
https://www.prnewswire.com/news-releases/valeant-announces-pricing-of-private-offering-of-senior-secured-notes-300529492.html
Valeant Announces Pricing Of Private Offering Of Senior Secured Notes
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has priced its...
valeantannouncespricingprivateoffering
https://www.prnewswire.com/news-releases/valeant-announces-launch-of-private-offering-of-notes-and-upsize-of-term-loans-300650245.html
Valeant Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant" or the "Company") today announced that Valeant Pharmaceuticals...
valeantannounceslaunchprivate
https://www.prnewswire.com/news-releases/research-reports-coverage-on-drug-delivery-stocks----valeant-pharma-delcath-systems-alkermes-and-adamis-pharma-625268623.html
Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and...
/PRNewswire/ -- This morning, Stock-Callers.com takes a closer look at Valeant Pharmaceuticals International Inc. (NYSE: VRX), Delcath Systems Inc. (NASDAQ:...
https://www.ibtimes.co.uk/allergan-rejects-47bn-offer-valeant-pharmaceuticals-1448314
Allergan Rejects $47bn Offer From Valeant Pharmaceuticals | IBTimes UK
May 13, 2014 - Proposal substantially undervalued Allergan, according to company.
valeant pharmaceuticalsallerganrejectsofferibtimes
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=3&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.medicaldaily.com/valeant-picks-astrazeneca-psoriasis-drug-after-amgen-exit-350530
Valeant Picks Up AstraZeneca Psoriasis Drug After Amgen Exit
Sep 1, 2015 - Valeant Pharmaceuticals buys the rights to AstraZeneca's late-stage experimental drug for psoriasis after it was dropped by Amgen Inc in May.
valeantpicksastrazenecapsoriasisdrug
https://www.acsh.org/news/2015/12/15/karma-ceuticals-payback-time-for-valeant
Karma-ceutical Payback Time for Valeant | American Council on Science and Health
Valeant Pharmaceuticals, a generic drug firm with a reputation far from sterling, is hurting from a nasty billion dollar payback. It incinerated that...
payback time
https://www.biospace.com/dendreon-corporation-enters-into-amended-agreement-with-valeant-in-connection-with-court-supervised-sales-process
Dendreon Corporation Enters Into Amended Agreement With Valeant In Connection With Court-Supervised...
https://www.prnewswire.com/news/valeant-pharmaceuticals-international%2C-inc./?page=4&pagesize=25
Valeant Pharmaceuticals International, Inc. News and Press Releases | PR Newswire
news and press releasesvaleant pharmaceuticalsinternationalincnewswire
https://www.fool.com/investing/2016/07/14/why-cree-harsco-and-valeant-pharmaceuticals-jumped.aspx
Why Cree, Harsco, and Valeant Pharmaceuticals Jumped Today | The Motley Fool
Jul 14, 2016 - These stocks contributed to the market's record run. Find out why.
valeant pharmaceuticalsthe motleycreeharsco
https://www.egyptindependent.com/tag/valeant/
Valeant Archives - Egypt Independent
valeantarchivesegyptindependent
https://www.foxbusiness.com/markets/valeant-in-talks-to-hire-perrigos-papa-as-ceo
Valeant in Talks to Hire Perrigo's Papa as CEO | Fox Business
Drugmaker Valeant Pharmaceuticals International is seeking to appoint Perrigo boss Joseph Papa as its new chief executive, a source familiar with the matter...
in talks
https://www.biospace.com/the-day-in-review-valeant-pharmaceuticals-international-rises-despite-mixed-trial-results
The Day In Review: Valeant Pharmaceuticals International Rises Despite Mixed Trial Results -...
the dayin reviewvaleant pharmaceuticals
https://www.prnewswire.com/news-releases/valeant-and-one-of-its-subsidiaries-announce-expiration-and-final-settlement-date-for-cash-tender-offers-for-senior-notes-300627761.html
Valeant And One Of Its Subsidiaries Announce Expiration And Final Settlement Date For Cash Tender...
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ("Valeant") announced today the expiration of the cash tender offers (the "Tender...
https://www.payscale.com/research/AE/Employer=Valeant_Pharmaceuticals/Reviews
Working at Valeant Pharmaceuticals in United Arab Emirates | PayScale
What's it like to work at Valeant Pharmaceuticals in United Arab Emirates? Visit PayScale to research current and former Valeant Pharmaceuticals employee...
united arab emiratesvaleant pharmaceuticalsworkingpayscale
https://www.science20.com/science_20/blog/coldfx_works_as_well_as_homeopathy_or_any_other_placebo_and_valeant_may_lose_a_lot_money_denying_that-169590
Cold-fX Works As Well As Homeopathy Or Any Other Placebo - And Valeant May Lose A Lot Money Denying...
Valeant Pharmaceuticals is in the British Columbia Supreme Court hoping to avoid lawsuit class-action status for ignoring their own scientists and claiming the...
https://www.biospace.com/it-s-official-valeant-to-buy-bankrupt-vaccine-maker-for-400-million-cash
It's Official: Valeant to Buy Bankrupt Vaccine Maker for $400 Million Cash - BioSpace
https://www.biospace.com/spending-spree-continues-as-valeant-officially-snags-salix-for-14-5-billion
Spending Spree Continues as Valeant Officially Snags Salix for $14.5 Billion - BioSpace
https://www.fool.com/investing/2017/08/09/finally-3-figures-from-valeants-second-quarter-rep.aspx
Finally! 3 Figures From Valeant's Second-Quarter Report That Demonstrate Improvement | The Motley...
Aug 9, 2017 - However, Valeant is far from being out of the woods.
https://kffhealthnews.org/morning-breakout/valeant-defends-its-activities-and-forms-committee-to-probe-pharmacy-relationships/
Valeant Defends Its Activities And Forms Committee To Probe Pharmacy Relationships - KFF Health News
Oct 28, 2015 - Other Valeant news reporting focuses on a Federal Trade Commission investigation of the company's contact lens business as well as the specialty pharmacy,...
https://www.biospace.com/valeant-pharmaceuticals-international-to-webcast-2009-annual-meeting-of-stockholders
Valeant Pharmaceuticals International to Webcast 2009 Annual Meeting of Stockholders - BioSpace
valeant pharmaceuticalsannual meetinginternationalwebcast
https://www.prnewswire.com/news-releases/valeant-pharmaceuticals-announces-the-addition-of-three-new-independent-directors-to-its-board-300233206.html
Valeant Pharmaceuticals Announces The Addition Of Three New Independent Directors To Its Board
/PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Dr. Fred Eshelman, Mr. Stephen Fraidin and Mr....